Clinical Trial Update: Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML) [Phase 2, Phase 3]

View source ↗

Summary

This document reports results from a randomized Phase 2/3 trial of decitabine as maintenance therapy for acute myeloid leukemia, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Dacogen (decitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myelogenous Leukemia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-03-04